Inactive Instrument

Press Releases POIT BIOP

Equities

RACA

US7305411099

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Lilly Completes Acquisition of POINT Biopharma	Dec. 27	PR
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 22, 2023	Dec. 18	PR
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023	Dec. 04	PR
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023	Nov. 20	AQ
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 1, 2023	Nov. 17	PR
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights	Nov. 13	AQ
Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma	Nov. 08	PR
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm	23-10-13	PR
POINT BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of POINT Biopharma Global, Inc. - PNT	23-10-06	BU
McCormick, Meta Platforms fall; Boeing, Point Biopharma rise, Tuesday, 10/3/2023	23-10-03	AQ
Shareholder Alert: Ademi LLP investigates whether POINT Biopharma Global, Inc. has obtained a Fair Price in its transaction with Eli Lilly	23-10-03	PR
POINT Biopharma Global : TENDER AND SUPPORT AGREEMENT - Form 8-K	23-10-03	PU
PNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of POINT Biopharma Global, Inc. Is Fair to Shareholders	23-10-03	BU
Lilly to Acquire POINT Biopharma to Expand Oncology Capabilities into Next-Generation Radioligand Therapies	23-10-03	PR
POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands	23-09-18	AQ
POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights	23-08-14	AQ
ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177	23-07-31	AQ
POINT Biopharma Expands Its Research with Next-Generation Isotopes, Publishing New Preclinical Data at SNMMI's Annual Congress	23-06-27	AQ
POINT Biopharma and AdvanCell to Collaborate in the Development of Lead-212-Labeled Radioligands	23-06-26	AQ
POINT Biopharma Expands Its Research with Next-Generation Isotopes, Publishing New Preclinical Data at SNMMI’s Annual Congress	23-06-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases POIT BIOP

Equities

RACA

US7305411099

Press Releases

Filters